Furthermore, TAM-derived IL-6 induced CD44+ stemlike cell expansion by activating STAT3, and blocking IL-6 with tocilizumab ablated CD44+ sphere formation in vitro and tumor growth in patient-derived HCC xenografts [100]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.